Form 4: Immunovant CEO Sells Shares
Insider Transaction (Form 4)
Eric Venker, Chief Executive Officer and a Director of Immunovant, Inc., sold 3,506 shares of common stock on October 1, 2026 for $34.11 per share.
Summary
- Option exercise/conversion: acquired 92,187 Common Stock at $14.46 ($1,333,024) on October 1, 2026; holds 346,467 after (Direct).
- Disposition to the issuer: disposed of 85,886 Common Stock at $33.65 ($2,890,064) on October 1, 2026; holds 260,581 after (Direct).
- Open-market sale: disposed of 3,506 Common Stock at $34.11 ($119,590) on October 2, 2026; holds 257,075 after (Direct).
- Option exercise/conversion: disposed of 92,187 Capped Value Appreciation Rights on October 1, 2026; holds 921,875 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $119,590 of stock on the open market.
Insider Transactions
Eric Venker — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 92,187 | $14 | $1.3M | 346,467 |
| 2026-10-01 | Disposition to the issuer | Common Stock | 85,886 | $34 | $2.9M | 260,581 |
| 2026-10-02 | Open-market sale | Common Stock | 3,506 | $34 | $119.6K | 257,075 |
| 2026-10-01 | Option exercise/conversion | Capped Value Appreciation Rights | 92,187 | — | — | 921,875 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (92,187 shares) |
| 2026-10-01 | Disposition to the issuer (85,886 shares) |
| 2026-10-02 | Open-market sale (3,506 shares) |
| 2026-10-01 | Option exercise/conversion (92,187 shares) |
Keywords
insider transaction, Form 4, IMVT, Immunovant, Inc., bearish, Eric Venker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.